Clinical trial
Usage of Acyclovir for Suppression of HIV-1 and HSV-2 Coinfected Persons in…
NCT00209313 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00209313 |
|---|---|
| Title | Usage of Acyclovir for Suppression of HIV-1 and HSV-2 Coinfected Persons in Cameroon |
| Official title | A Randomized, Double-blind, Placebo-controlled Crossover Trial of Acyclovir for Suppression of HSV and HIV Shedding in HIV-1, HSV-2 Coinfected Persons in Cameroon |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Collaborators | Institute for the Development of Africa |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | HIV-1 and HSV-2 Coinfection, HIV Infections |
| Intervention type | Drug |
| Interventions | Acyclovir |
| Enrollment | 40 |
| Start date | Mar 1, 2005 |
| Completion | Apr 1, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | Dec 16, 2011 |
| Countries | Cameroon |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: